Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TBC1 Domain Family, Member 4 (TBC1D4) (C-Term) Peptide

TBC1D4 Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN1541344

Aperçu rapide pour TBC1 Domain Family, Member 4 (TBC1D4) (C-Term) Peptide (ABIN1541344)

Antigène

TBC1D4 (TBC1 Domain Family, Member 4 (TBC1D4))

Origine

Humain

Source

  • 4
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    C-Term

    Séquence

    EMEKIITQVF EMDISKQLHA YEVEYHVLQD ELQESSYSCE DSETLEKLER

    Attributs du produit

    This is a synthetic peptide designed for use in combination with anti-TBC1D4 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Indications d'application

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Conseil sur la manipulation

    Avoid repeated freeze-thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    TBC1D4 (TBC1 Domain Family, Member 4 (TBC1D4))

    Sujet

    TBC1D4 may act as a GTPase-activating protein for RAB2A, RAB8A, RAB10 and RAB14. Isoform 2 promotes insulin-induced glucose transporter SLC2A4/GLUT4 translocation at the plasma membrane, thus increasing glucose uptake.

    Alias Symbols: AS160, DKFZp779C0666

    Protein Size: 1298

    Poids moléculaire

    146 kDa

    ID gène

    9882

    NCBI Accession

    NM_014832, NP_055647

    UniProt

    O60343
Vous êtes ici:
Chat with us!